Literature DB >> 2872165

Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells.

A Urisu, J L Cowell, C R Manclark.   

Abstract

[35S]methionine-labeled Bordetella pertussis adhered to monolayers of WiDr cells, an epitheliumlike cell line from a human intestinal carcinoma. Adherence was proportional to the density of the WiDr cells and to the concentration of B. pertussis in the assay. Adherence of virulent phase I strains Tohama phase I, 114, and BP338 was much greater than adherence of avirulent strains Tohama phase III and 423 phase IV. Mutants deficient in the production of the filamentous hemagglutinin (FHA) were hemagglutination negative and adhered to WiDr cells much less efficiently than the parent strains. Preincubation of B. pertussis cells with FHA increased their hemagglutination activity and adherence to WiDr cells. Goat antibody to FHA inhibited, in a dose-dependent manner, the adherence of strain Tohama I but not the adherence of FHA-deficient mutant Tohama 325. At similar protein concentrations, normal goat antibody, goat antibody to pertussis toxin, or the Fab fragments of goat antibody to serotype 2 fimbriae had no effect on adherence. Also, an FHA-positive strain without fimbriae showed high adherence, while a fimbriated FHA-deficient mutant adhered poorly. Our data indicate that FHA plays a major role in adherence of B. pertussis to human WiDr cells. Fimbriae do not appear to mediate attachment of B. pertussis to WiDr cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872165      PMCID: PMC260913          DOI: 10.1128/iai.52.3.695-701.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Characterization of the WIDR: a human colon carcinoma cell line.

Authors:  P Noguchi; R Wallace; J Johnson; E M Earley; S O'Brien; S Ferrone; M A Pellegrino; J Milstien; C Needy; W Browne; J Petricciani
Journal:  In Vitro       Date:  1979-06

2.  Bordetella pertussis serotypes in the United States.

Authors:  G Eldering; J Holwerda; A Davis; J Baker
Journal:  Appl Microbiol       Date:  1969-10

3.  An assay of Bordetella pertussis adhesion to tissue-culture cells.

Authors:  K Redhead
Journal:  J Med Microbiol       Date:  1985-02       Impact factor: 2.472

4.  Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies.

Authors:  L I Irons; L A Ashworth; P Wilton-Smith
Journal:  J Gen Microbiol       Date:  1983-09

5.  Separation and purification of the hemagglutinins from Bordetella pertussis.

Authors:  Y Sato; J L Cowell; H Sato; D G Burstyn; C R Manclark
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

6.  Progressive cough associated with lymphocytic leukemoid reaction in an infant.

Authors:  M I Marks; T Stacy; H F Krous
Journal:  J Pediatr       Date:  1980-07       Impact factor: 4.406

7.  Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.

Authors:  L A Ashworth; R B Fitzgeorge; L I Irons; C P Morgan; A Robinson
Journal:  J Hyg (Lond)       Date:  1982-06

8.  Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.

Authors:  M Oda; J L Cowell; D G Burstyn; C R Manclark
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

9.  Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization.

Authors:  E Hewlett; J Wolff
Journal:  J Bacteriol       Date:  1976-08       Impact factor: 3.490

10.  Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.

Authors:  D G Burstyn; L J Baraff; M S Peppler; R D Leake; J St Geme; C R Manclark
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  37 in total

1.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

3.  Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

Authors:  Michael W Henderson; Carol S Inatsuka; Amanda J Sheets; Corinne L Williams; David J Benaron; Gina M Donato; Mary C Gray; Erik L Hewlett; Peggy A Cotter
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

4.  Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.

Authors:  Annika Elomaa; Abdolreza Advani; Declan Donnelly; Mia Antila; Jussi Mertsola; Hans Hallander; Qiushui He
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis.

Authors:  T M Finn; R Shahin; J J Mekalanos
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

6.  A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterations.

Authors:  C K Lee; A L Roberts; T M Finn; S Knapp; J J Mekalanos
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  The prodomain of the Bordetella two-partner secretion pathway protein FhaB remains intracellular yet affects the conformation of the mature C-terminal domain.

Authors:  Christopher R Noël; Joseph Mazar; Jeffrey A Melvin; Jessica A Sexton; Peggy A Cotter
Journal:  Mol Microbiol       Date:  2012-10-05       Impact factor: 3.501

8.  Contribution of Bordetella bronchiseptica filamentous hemagglutinin and pertactin to respiratory disease in swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Crystal L Loving
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

9.  Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis.

Authors:  S J Barenkamp; E Leininger
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 10.  A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.

Authors:  S S Patel; A J Wagstaff
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.